search
Back to results

Behavioral Activation Teletherapy to Increase Physical Activity (BAT)

Primary Purpose

Depression, Depressive Disorder, Depressive Symptoms

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Behavioral Activation Teletherapy
Sponsored by
University of Texas Southwestern Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Depression focused on measuring Therapy, Teletherapy, Physical Activity, Exercise

Eligibility Criteria

18 Years - 64 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Be18-64 years old;
  • Able and willing to provide informed consent;
  • Have moderate-to-severe depressive symptoms, with a PHQ-9 score ≥ 10;
  • Insufficient moderate-to-vigorous physical activity (< 90 minutes a week);
  • Demonstrated interest in increasing physical activity;
  • Have a smartphone.

Exclusion Criteria:

  • Have any current, past, or lifetime manic or hypomanic episode, psychosis, schizophrenia or schizophreniform disorder;
  • Be currently experiencing active suicidal ideation (i.e. with suicidal thoughts, plan, and intent) or at a high risk for suicide during the course of the study, as designated by the PI;
  • Have a medical condition that prohibits physical activity; be medically prohibited to exercise by primary care physician (PCP), OB-GYN (obstetrician-gynecologist) or study MD.
  • Be in current, active psychotherapy

Sites / Locations

  • University of Texas Southwestern Medical CenterRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Behavioral Activation Teletherapy

Arm Description

All eligible participants will be assigned to receive the behavioral activation teletherapy intervention.

Outcomes

Primary Outcome Measures

Feasibility and acceptability - Screening
Number of participants screened per week (Goal 1-2 per week)
Feasibility and acceptability - Recruitment
Percentage of screened participants enrolled (Goal: 50%)
Intervention Adherence
Percentage of intervention sessions attended (goal 75%)
Intervention Validity via Quality of Behavioral Activation Short Form
Fidelity on supervisor's structured feedback form with average item score ≥3. The 14-item scale has each item ranging from 0-6, with higher values indicating higher levels of fidelity.
Participant retention
Percentage of PHQ-9 assessments completed (Goal: 80%)
Participant outcome completion
Percentage of valid Fitbit wear days > 12 hours (Goal: 80%)

Secondary Outcome Measures

Depressive symptoms - 9-item Patient Health Questionnaire
Change in self-Reported Depressive Symptoms, analyzed using linear mixed effects modeling controlling for baseline depressive symptoms and additional covariates
Physical activity - self-report days per week
Change in self-reported frequency of physical activity (days per week), analyzed using linear mixed effects modeling controlling for baseline physical activity and additional covariates
Physical activity - self-report minutes per day
Change in self-reported frequency of physical activity (minutes per day), analyzed using linear mixed effects modeling controlling for baseline physical activity and additional covariates
Physical activity - Fitbit step counter active minutes
Change in objective data from Fitbit of "active minutes", using linear mixed effects modeling controlling for baseline physical activity and additional covariates
Physical activity - Fitbit step counter step count
Change in objective data from Fitbit of "step count", using linear mixed effects modeling controlling for baseline physical activity and additional covariates

Full Information

First Posted
July 21, 2021
Last Updated
September 23, 2023
Sponsor
University of Texas Southwestern Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT04990401
Brief Title
Behavioral Activation Teletherapy to Increase Physical Activity
Acronym
BAT
Official Title
Adapted Tele-Behavioral Activation Targeted to Increase Physical Activity in Depression
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Recruiting
Study Start Date
August 31, 2021 (Actual)
Primary Completion Date
June 2024 (Anticipated)
Study Completion Date
December 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Texas Southwestern Medical Center

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This is a pilot study of acceptability, feasibility, and preliminary efficacy of a brief, 10-session Behavioral Activation intervention delivered via teletherapy to increase physical activity and treat depressive symptoms.
Detailed Description
This is a one-site, two-phase study that will use an initial group of individuals between the ages of 18 and 64 who have moderate to severe depressive symptoms and exercise less than 90 minutes a week. In both phases, participants will complete a total of 8 behavioral activation teletherapy sessions used to increase physical activity, followed by two biweekly booster sessions, for a total of 10 sessions. Participants will also complete weekly assessments remotely for both phases of the study. The screening visit and final intervention session will be in-person, and all other visits will be via telehealth. Participants will have the option to come to the clinic if they prefer. In the initial phase (n = 15), participants who completed the intervention will have the option to participate in a focus group, and participants who partially completed the intervention will have the option to participate in a semi-structured interview. The total duration of phase one is 14 weeks. This initial phase will allow the researchers to refine and optimize the intervention to be delivered in the second phase. In the second/pilot phase (n = 50), participants will complete a one-month and a two-month follow-up after the 10 intervention sessions. The total duration for phase two is 22 weeks. Participants for both phases of the study will wear a Fitbit during the duration of their study participation, in order to record step count.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Depression, Depressive Disorder, Depressive Symptoms, Depressive Episode
Keywords
Therapy, Teletherapy, Physical Activity, Exercise

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
All eligible participants will receive the behavioral activation teletherapy intervention in this single-arm study.
Masking
None (Open Label)
Allocation
N/A
Enrollment
65 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Behavioral Activation Teletherapy
Arm Type
Experimental
Arm Description
All eligible participants will be assigned to receive the behavioral activation teletherapy intervention.
Intervention Type
Behavioral
Intervention Name(s)
Behavioral Activation Teletherapy
Intervention Description
A total of 10 teletherapy sessions to be delivered over 12-14 weeks, designed to increase physical activity among depressed individuals.
Primary Outcome Measure Information:
Title
Feasibility and acceptability - Screening
Description
Number of participants screened per week (Goal 1-2 per week)
Time Frame
1 week
Title
Feasibility and acceptability - Recruitment
Description
Percentage of screened participants enrolled (Goal: 50%)
Time Frame
1 week
Title
Intervention Adherence
Description
Percentage of intervention sessions attended (goal 75%)
Time Frame
Up to 14 weeks
Title
Intervention Validity via Quality of Behavioral Activation Short Form
Description
Fidelity on supervisor's structured feedback form with average item score ≥3. The 14-item scale has each item ranging from 0-6, with higher values indicating higher levels of fidelity.
Time Frame
Up to 14 weeks
Title
Participant retention
Description
Percentage of PHQ-9 assessments completed (Goal: 80%)
Time Frame
Up to 22 weeks
Title
Participant outcome completion
Description
Percentage of valid Fitbit wear days > 12 hours (Goal: 80%)
Time Frame
Up to 22 weeks
Secondary Outcome Measure Information:
Title
Depressive symptoms - 9-item Patient Health Questionnaire
Description
Change in self-Reported Depressive Symptoms, analyzed using linear mixed effects modeling controlling for baseline depressive symptoms and additional covariates
Time Frame
Up to 22 weeks
Title
Physical activity - self-report days per week
Description
Change in self-reported frequency of physical activity (days per week), analyzed using linear mixed effects modeling controlling for baseline physical activity and additional covariates
Time Frame
Up to 22 weeks
Title
Physical activity - self-report minutes per day
Description
Change in self-reported frequency of physical activity (minutes per day), analyzed using linear mixed effects modeling controlling for baseline physical activity and additional covariates
Time Frame
Up to 22 weeks
Title
Physical activity - Fitbit step counter active minutes
Description
Change in objective data from Fitbit of "active minutes", using linear mixed effects modeling controlling for baseline physical activity and additional covariates
Time Frame
Up to 22 weeks
Title
Physical activity - Fitbit step counter step count
Description
Change in objective data from Fitbit of "step count", using linear mixed effects modeling controlling for baseline physical activity and additional covariates
Time Frame
Up to 22 weeks
Other Pre-specified Outcome Measures:
Title
Mediation of intervention through a number of pathways
Description
Testing whether the physical activity to depression reduction pathway is mediated by changes in (a) positive and negative affect; (b) anhedonia, (c), fatigue, (d) self-esteem, (e) overall depressive symptoms and (f) emotion regulation. For each potential mediator, both a direct and indirect pathway will be tested. First, the mediational model should meet the goodness of fit criteria (e.g., a non-significant X2, fit indices greater than .90 and significant path coefficients) and second, when a direct effect path is added to the model this path is either non-significant or adds little improvement in the overall predictive value of the model (i.e., increase in R2).
Time Frame
Up to 22 weeks, using mediating timepoints post-session at Weeks 0, 3 and 7
Title
Minimum number of therapy sessions needed to achieve depression remission
Description
The minimum number of completed therapy sessions (1-10) needed to achieve depression remission, analyzed through discrete-time survival analysis.
Time Frame
Up to 14 weeks
Title
Depressive symptoms - IDS-SR
Description
Change in self-reported Inventory of Depressive Symptoms (IDS-SR), analyzed using linear mixed effects modeling controlling for baseline depressive symptoms and additional covariates
Time Frame
Up to 22 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
64 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Be18-64 years old; Able and willing to provide informed consent; Have moderate-to-severe depressive symptoms, with a PHQ-9 score ≥ 10; Insufficient moderate-to-vigorous physical activity (< 90 minutes a week); Demonstrated interest in increasing physical activity; Have a smartphone. Exclusion Criteria: Have any current, past, or lifetime manic or hypomanic episode, psychosis, schizophrenia or schizophreniform disorder; Be currently experiencing active suicidal ideation (i.e. with suicidal thoughts, plan, and intent) or at a high risk for suicide during the course of the study, as designated by the PI; Have a medical condition that prohibits physical activity; be medically prohibited to exercise by primary care physician (PCP), OB-GYN (obstetrician-gynecologist) or study MD. Be in current, active psychotherapy
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Elizabeth Dedrick
Phone
214-648-5020
Email
Elizabeth.Dedrick@UTSouthwestern.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Joseph M Trombello, PhD, ABPP
Phone
214-648-0162
Email
Joseph.Trombello@UTSouthwestern.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Joseph M Trombello, PhD, ABPP
Organizational Affiliation
University of Texas Southwestern Medical Center
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Madhukar Trivedi, MD
Organizational Affiliation
University of Texas Southwestern Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Texas Southwestern Medical Center
City
Dallas
State/Province
Texas
ZIP/Postal Code
75235
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Elizabeth Dedrick
Phone
214-648-5020
Email
Elizabeth.Dedrick@UTSouthwestern.edu

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
If other investigators are interested in accessing data, they may contact the principal investigator in writing.

Learn more about this trial

Behavioral Activation Teletherapy to Increase Physical Activity

We'll reach out to this number within 24 hrs